Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S157000, C546S158000
Reexamination Certificate
active
10508185
ABSTRACT:
This invention comprises the novel compounds of formula (I)wherein r, t, Y1, Y2, R1, R2, R3, R5, R6and R7have defined meanings, having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
REFERENCES:
patent: 5968952 (1999-10-01), Venet et al.
patent: 6037350 (2000-03-01), Venet et al.
patent: WO 97/16443 (1997-05-01), None
patent: WO 97/21701 (1997-06-01), None
patent: WO 97/36876 (1997-10-01), None
patent: WO 98/40383 (1998-09-01), None
patent: WO 98/49157 (1998-11-01), None
patent: WO 98/55124 (1998-12-01), None
patent: WO 00/01388 (2000-01-01), None
patent: WO 00/01411 (2000-01-01), None
patent: WO 00/12498 (2000-03-01), None
patent: WO 00/12499 (2000-03-01), None
patent: WO 00/39082 (2000-07-01), None
patent: WO 00/47574 (2000-08-01), None
patent: WO 01/53289 (2001-07-01), None
patent: WO 02/24686 (2002-03-01), None
patent: WO 02/24687 (2002-03-01), None
Kohl et al., “Selective Inhibition of ras-Dependent Transformation by a Famesyltransferase Inhibitor,” Science, 1993, pp. 1934-1937, vol. 260, No. 5116.
Rak et al., “Mutant ras Oncogenes Upregulate VEGF/VPF Expression: Implications for Induction and Inhibition of Tumor Anglogenesis,”Cancer Research. 1995, pp. 4575-4580, vol. 55, No. 20.
PCT International Search Report dated Jul. 24, 2003 for PCT Application. No. PCT/EP03/02874 which relates to U.S. Patent Application filed herewith.
Angibaud Patrick Rene
Breslin Henry Joseph
Meyer Christophe
Venet Marc Gaston
Janssen Pharmaceutica N.V.
Truong Tamthom N.
Wilson James O.
LandOfFree
Benzylimidazolyl substituted 2-quinoline and quinazoline... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzylimidazolyl substituted 2-quinoline and quinazoline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylimidazolyl substituted 2-quinoline and quinazoline... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3734541